{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:57:20Z","timestamp":1782755840515,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,8,28]],"date-time":"2005-08-28T00:00:00Z","timestamp":1125187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2005,8,28]],"date-time":"2005-08-28T00:00:00Z","timestamp":1125187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To assess patient views regarding the value of genetic counselling for familial pancreas cancer in the absence of predictive genetic testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and methods<\/jats:title>\n            <jats:p>At-risk adults with three or more relatives with pancreas cancer received genetic counselling prior to research screening via endoscopic ultrasound. Questionnaires were mailed after the visit to assess perceived value of the counselling session.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ninety-three percent of respondents felt genetic counselling for pancreas cancer was helpful despite the lack of a causative gene, while only 7% felt that it should not be offered until such a gene is discovered. Over half of respondents believed the pancreas cancer in their family was caused by a gene mutation, and 42% thought they had inherited the mutation. The average perceived lifetime risk of developing pancreas cancer was 51%, and 87% of respondents would ultimately seek predictive genetic testing. When more information is gained, 89% would be interested in another genetic counselling session, and 82% would recommend current genetic counselling for pancreas cancer to a friend or relative with a family history of the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite the lack of an identified major causative gene for pancreas cancer, respondents found genetic counselling for this malignancy to be helpful. These patients perceive their personal cancer risk to be high, and would seek predictive genetic testing if it were available. Referral for genetic counselling should be offered to appropriate individuals.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1897-4287-3-3-115","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T16:11:52Z","timestamp":1336666312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patient Perspective on the Value of Genetic Counselling for Familial Pancreas Cancer"],"prefix":"10.1186","volume":"3","author":[{"given":"Jennifer E.","family":"Axilbund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran A.","family":"Brune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia I.","family":"Canto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda C","family":"Brehon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Wroblewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance A.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,28]]},"reference":[{"key":"47_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djh017","volume":"96","author":"D Braithwaite","year":"2004","unstructured":"Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S: Psychological impact of genetic counselling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2004, 96: 122\u2013133.","journal-title":"J Natl Cancer Inst"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5694\/j.1326-5377.2003.tb05069.x","volume":"178","author":"PN Butow","year":"2003","unstructured":"Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM: Psychological outcomes and risk perception after fenetic testing and counselling in breast cancer: A systematic review. Med J Aust 2003, 178: 77\u201381.","journal-title":"Med J Aust"},{"key":"47_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0277-9536(01)00133-2","volume":"54","author":"B Meiser","year":"2002","unstructured":"Meiser B, Halliday JL: What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002, 54: 1463\u20131470. 10.1016\/S0277-9536(01)00133-2","journal-title":"Soc Sci Med"},{"key":"47_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994, 73: 643\u2013651. 10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","journal-title":"Cancer"},{"key":"47_CR5","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81: 1879\u20131886. 10.1093\/jnci\/81.24.1879","journal-title":"J Natl Cancer Inst"},{"key":"47_CR6","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","volume":"64","author":"AP Klein","year":"2004","unstructured":"Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH: Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004, 64: 2634\u20132638. 10.1158\/0008-5472.CAN-03-3823","journal-title":"Cancer Res"},{"key":"47_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/gepi.1102","volume":"23","author":"AP Klein","year":"2002","unstructured":"Klein AP, Beaty TH, Bailey-Wilson JE, Brune KA, Hruban RH, Petersen GM: Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol 2002, 23: 133\u2013149. 10.1002\/gepi.1102","journal-title":"Genet Epidemiol"},{"key":"47_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1542-3565(04)00244-7","volume":"2","author":"MI Canto","year":"2004","unstructured":"Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jagannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH: Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004, 2: 606\u2013621. 10.1016\/S1542-3565(04)00244-7","journal-title":"Clin Gastroenterol Hepatol"},{"key":"47_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJM199703203361202","volume":"336","author":"FM Giardiello","year":"1997","unstructured":"Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, Booker SV, Parker RD, Hamilton SR: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997, 336: 823\u2013827. 10.1056\/NEJM199703203361202","journal-title":"N Engl J Med"},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2003.18.114","volume":"21","author":"American Society of Clinical Oncology policy statement update","year":"2003","unstructured":"American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 2003, 21: 1\u201310. 10.1200\/JCO.2003.18.114","journal-title":"J Clin Oncol"},{"key":"47_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1034\/j.1399-0004.2003.00093.x","volume":"63","author":"S Creighton","year":"2003","unstructured":"Creighton S, Almqvist EW, MacGregor D, Fernandez B, Hogg H, Beis J, Welch JP, Riddell C, Lokkesmoe R, Khalifa M, MacKenzie J, Sajoo A, Farrell S, Robert F, Shugar A, Summers A, Meschino W, Allingham-Hawkins D, Chiu T, Hunter A, Allanson J, Hare H, Schween J, Collins L, Sanders S, Greenberg C, Cardwell S, Lemire E, MacLeod P, Hayden MR: Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet 2003, 63: 462\u2013475. 10.1034\/j.1399-0004.2003.00093.x","journal-title":"Clin Genet"},{"key":"47_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/oxfordjournals.jncimonographs.a024210","volume":"25","author":"RT Croyle","year":"1999","unstructured":"Croyle RT, Lerman C: Risk communication in genetic testing for cancer susceptibility. J Nat Cancer Inst Monogr 1999, 25: 59\u201366.","journal-title":"J Nat Cancer Inst Monogr"},{"key":"47_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cdp.2003.12.001","volume":"28","author":"K Honda","year":"2004","unstructured":"Honda K, Neugut AI: Associations between perceived cancer risk and established risk factors in a national community sample. Cancer Detect Prev 2004, 28: 1\u20137. 10.1016\/j.cdp.2003.12.001","journal-title":"Cancer Detect Prev"},{"key":"47_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/pmed.1994.1042","volume":"23","author":"KJ Helzlsouer","year":"1994","unstructured":"Helzlsouer KJ, Ford DE, Hayward RS, Midzenski M, Perry H: Perceived risk of cancer and practice of cancer prevention behaviors among employees in an oncology center. Prev Med 1994, 23: 302\u2013308. 10.1006\/pmed.1994.1042","journal-title":"Prev Med"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1897-4287-3-3-115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1897-4287-3-3-115\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1897-4287-3-3-115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:04:58Z","timestamp":1630613098000},"score":1,"resource":{"primary":{"URL":"https:\/\/hccpjournal.biomedcentral.com\/articles\/10.1186\/1897-4287-3-3-115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,28]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1186\/1897-4287-3-3-115","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,28]]},"assertion":[{"value":"15 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"115"}}